Terms: = Germ cell tumor AND ABL2, ARG, 27, ENSG00000143322, P42684, ABLL, RP11-177A2_3 AND Prognosis
9713 results:
1. Malignant melanotic schwannoma of the cervical spinal cord: a case report.
Chen S; Wei Y
BMC Neurol; 2024 May; 24(1):181. PubMed ID: 38816740
[TBL] [Abstract] [Full Text] [Related]
2. Risk factors, impact and treatment of postoperative lymphatic leakage in children with abdominal neuroblastoma operated on by laparotomy.
Feng J; Mou J; Yang S; Ren Q; Chang S; Yang W; Cheng H; Chang X; Zhu Z; Han J; Qin H; Wang H; Ni X
BMC Surg; 2024 May; 24(1):168. PubMed ID: 38811926
[TBL] [Abstract] [Full Text] [Related]
3. A novel lateral myelotomy approach for the treatment of lateral or ventrolateral spinal gliomas.
Hang G; Gong Y; Xie H; Xie T
Acta Neurochir (Wien); 2024 May; 166(1):237. PubMed ID: 38809310
[TBL] [Abstract] [Full Text] [Related]
4. Micropeptide AF127577.4-ORF hidden in a lncRNA diminishes glioblastoma cell proliferation via the modulation of ERK2/METTL3 interaction.
Du B; Zhang Z; Jia L; Zhang H; Zhang S; Wang H; Cheng Z
Sci Rep; 2024 May; 14(1):12090. PubMed ID: 38802444
[TBL] [Abstract] [Full Text] [Related]
5. Non-metastatic primary neuroendocrine neoplasms of the breast: a reference cancer center's experience of a heterogenous entity.
Püsküllüoğlu M; Grela-Wojewoda A; Ambicka A; Pacholczak-Madej R; Pietruszka A; Mucha-Małecka A; Rudzińska A; Ziobro M; Ryś J; Mituś JW
Front Endocrinol (Lausanne); 2024; 15():1217495. PubMed ID: 38800480
[TBL] [Abstract] [Full Text] [Related]
6. Autoimmune Encephalitis following Checkpoint Inhibitor Therapy in a Patient with Metastatic Melanoma in Complete Remission.
Civardi G; Medioli A; Braghieri C; Ambroggi M; Immovilli P; Orsucci S; Contini P; Aronica G; Cavanna L
Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792910
[TBL] [Abstract] [Full Text] [Related]
7. Neuroendocrine carcinoma of the endometrium: a retrospective analysis of data from a single center.
Liu X; Tian Y; Yan S; Fu H; Si L; Lai T; Mao M; Wang Q; Bai J; Li H; Guo R
BMC Cancer; 2024 May; 24(1):636. PubMed ID: 38789995
[TBL] [Abstract] [Full Text] [Related]
8. [The pathological characteristics and prognostic analysis of medullary thyroid microcarcinoma].
Li DP; Zhang JM; Zhang YH; Hu LF; Gao Y; Wei SF; Zheng XQ
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1825-1830. PubMed ID: 38782750
[No Abstract] [Full Text] [Related]
9. Long-term outcome and fertility results of intraplacental choriocarcinoma: a retrospective study of 14 patients and literature review.
Liu Y; Song X; Zhang H; Feng F; Zhao J; Yang J; Ren T; Wan X; Jiang F; Li Y; Xiang Y
Orphanet J Rare Dis; 2024 May; 19(1):214. PubMed ID: 38778412
[TBL] [Abstract] [Full Text] [Related]
10. mRNA markers for survival prediction in glioblastoma multiforme patients: a systematic review with bioinformatic analyses.
Azimi P; Yazdanian T; Ahmadiani A
BMC Cancer; 2024 May; 24(1):612. PubMed ID: 38773447
[TBL] [Abstract] [Full Text] [Related]
11. Risk factor analysis and nomogram development and verification for medullary carcinoma of the colon using SEER database.
Yang L; Yu L; Zhou Q; Liu L; Shen N; Li N
Sci Rep; 2024 May; 14(1):11426. PubMed ID: 38763982
[TBL] [Abstract] [Full Text] [Related]
12. Superficial fibromas with CTNNB1 mutation.
Kuntze A; Meliß RR; Ermert L; Falkenberg KD; Puller AC; Trautmann M; Hartmann W; Wardelmann E
Genes Chromosomes Cancer; 2024 May; 63(5):e23247. PubMed ID: 38757718
[TBL] [Abstract] [Full Text] [Related]
13. A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification.
Woo CS; Ho RS; Ho G; Lau HT; Fong CH; Chang JY; Leung EK; Tang LC; Ma IK; Lee AC; Lui DT; Woo YC; Chow WS; Leung GK; Tan KC; Lam KS; Lee CH
Front Endocrinol (Lausanne); 2024; 15():1368944. PubMed ID: 38756997
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic nomogram in middle-aged and elderly patients with chordoma: A SEER-based study.
Ouyang C; Sun Y; Li Y; Jiang M; Nong L; Gao G
J Orthop Surg (Hong Kong); 2024; 32(2):10225536241254208. PubMed ID: 38744697
[TBL] [Abstract] [Full Text] [Related]
15. [Predicting the effectiveness of organ-preserving treatment of choroidal melanoma using optical coherence tomography data].
Stoyukhina AS
Vestn Oftalmol; 2024; 140(2. Vyp. 2):16-20. PubMed ID: 38739126
[TBL] [Abstract] [Full Text] [Related]
16. EGCG Disrupts the LIN28B/Let-7 Interaction and Reduces Neuroblastoma Aggressiveness.
Cocchi S; Greco V; Sidarovich V; Vigna J; Broso F; Corallo D; Zasso J; Re A; Rosatti EF; Longhi S; Defant A; Ladu F; Sanna V; Adami V; D'Agostino VG; Sturlese M; Sechi M; Aveic S; Mancini I; Sighel D; Quattrone A
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732012
[TBL] [Abstract] [Full Text] [Related]
17. CDCA3 is a potential biomarker for glioma malignancy and targeted therapy.
Han C; Liu S; Ji Y; Hu Y; Zhang J
Medicine (Baltimore); 2024 May; 103(19):e38066. PubMed ID: 38728485
[TBL] [Abstract] [Full Text] [Related]
18. Glioblastoma: a comprehensive approach combining bibliometric analysis, Latent Dirichlet Allocation, and HJ-Biplot : Glioblastoma insights and trends: a 49-year bibliometric analysis.
Montes-Escobar K; de la Hoz-M J; Castillo-Cordova P; Duran-Ospina JP; Bravo-Saltos RK; Lapo-Talledo GJ; Siteneski A
Neurosurg Rev; 2024 May; 47(1):209. PubMed ID: 38724684
[TBL] [Abstract] [Full Text] [Related]
19. Glioma.
Weller M; Wen PY; Chang SM; Dirven L; Lim M; Monje M; Reifenberger G
Nat Rev Dis Primers; 2024 May; 10(1):33. PubMed ID: 38724526
[TBL] [Abstract] [Full Text] [Related]
20. Temozolomide resistance mechanisms: unveiling the role of translesion DNA polymerase kappa in glioblastoma spheroids in vitro.
Ribeiro DL; Latancia MT; de Souza I; Ariwoola AA; Mendes D; Rocha CRR; Lengert AVH; Menck CFM
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38717250
[TBL] [Abstract] [Full Text] [Related]
[Next]